High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy-Reference-Cited by-同舟云学术

High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy

Published:2013-12-06 Issue:2 Volume:6 Page:483-492
ISSN:1942-0870
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Liu Yuqi,Caffry Isabelle,Wu Jiemin,Geng Steven B,Jain Tushar,Sun Tingwan,Reid Felicia,Cao Yuan,Estep Patricia,Yu Yao,Vásquez Maximiliano,Tessier Peter M,Xu Yingda

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.27431

Reference43 articles.

1. Therapeutic antibodies: Market considerations, disease targets and bioprocessing

2. Drake AW, Papalia GA. Biophysical Considerations for Development of Antibody-Based Therapeutics. In: Tabrizi MA, Bornstein GG, Klakamp SL, editors. Development of Antibody-Based Therapeutics. New York, NY: Springer New York; 2012. page 95–139.

3. Developability studies before initiation of process development

4. Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates

5. Sathish H, Angell N, Lowe D, Shah A, Bishop S. Application of Biophysics to the Early Developability Assessment of Therapeutic Candidates and Its Application to Enhance Developability Properties. In: Narhi LO, editor. Biophysics for Therapeutic Protein Development. Springer New York; 2013. page 127–46.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive overview of recent advances in generative models for antibodies;Computational and Structural Biotechnology Journal;2024-12

2. Developability considerations for bispecific and multispecific antibodies;mAbs;2024-08-27

3. Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows;mAbs;2024-07-31

4. DOTAD: A Database of Therapeutic Antibody Developability;Interdisciplinary Sciences: Computational Life Sciences;2024-03-26

5. Reduction of monoclonal antibody viscosity using interpretable machine learning;mAbs;2024-03-12